Echocardiographic and biochemical evidences of cardioprotection by dapagliflozin in non-diabetic models exposed to sequential anthracyclines and trastuzumab therapy
Comprehensive echocardiographic assessment of the diastolic cardiac function in children treated for acute lymphoblastic leukemia, preliminary results.
Speaker:
Doctor J. Haponiuk-Skwarlinska (Warsaw, PL)
The utility of serial global longitudinal strain and biomarkers in identifying subclinical cardiotoxicity in cancer patients receiving anthracycline or trastuzumab therapy